September 30, 2021 01:18 PM EDT
Manufacturing

Eli Lil­ly is­sues re­sponse to Form 483 at In­di­anapo­lis plant

Josh Sullivan

Af­ter an Aug. 12 dat­ed Form 483 called out Eli Lil­ly’s In­di­anapo­lis ster­ile in­jecta­bles plant for sev­er­al laps­es in qual­i­ty, the com­pa­ny has is­sued a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times